Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic

NCT02668120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2018-10-15

No results posted yet for this study

Summary

Background : Chronic histiocytic intervillositis is a rare placental disease linked with poor perinatal outcome. In a recent study, a major antenatal increased alkaline phosphatase was suspected in patients affected by chronic histiocytic intervillositis. This increase may correspond to the release of alkaline phosphatase by the syncytiotrophoblaste prejudiced in this pathology.

Aim : To confirm the association between high levels of alkaline phosphatase and the occurrence of chronic histiocytic intervillositis.

Conditions

  • Chronic Histiocytosis

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Damien Subtil, MD, PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-16
Primary Completion
2017-04-11
Completion
2017-04-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02668120 on ClinicalTrials.gov